Currently predicting for Thu, 4 Jun 2026

CRIS Prediction Chart

CRIS Predictions History

Latest community submissions for CRIS.
Predictor Target Session Target Price Result Direction Accuracy Score
JS JS Pro
Jan 28, 2019 $1.24 -94.51% $1.13 V 90.30% 0
JS JS Pro
Feb 8, 2018 $0.566 -98.97% $0.550 V 97.30% 0
Dec 22, 2017 $0.661 -99.12% $0.770 V 85.90% 0
JS JS Pro
Dec 7, 2017 $0.795 -99.05% $0.84 V 94.70% 0
JS JS Pro
Sep 18, 2017 $1.70 -99.03% $1.76 V 96.60% 0
Sep 18, 2017 $1.51 -99.14% $1.76 V 85.80% 0
JS JS Pro
Jun 12, 2017 $1.78 -98.98% $1.74 V 97.70% 0
Jon Jon Merchant
Jun 12, 2017 $1.80 -98.97% $1.74 X 96.60% 0
bbullish2 bbullish2 Merchant @bbullish2.7792
Jun 12, 2017 $1.81 -98.96% $1.74 X 96.00% 0
Jon Jon Merchant
Jun 5, 2017 $1.95 -98.89% $1.76 X 89.20% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CRIS with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT CURIS
Curis
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myeloid leukemia and myelodysplastic syndromes; and CI-8993, a monoclonal antibody designed to antagonize t...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE